Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus

Journal of Endocrinological Investigation

Volumn 35, Issue 3, 2012, Pages 269-273

  Fu, C ^a   Ji, L ^b   Wang, W ^a   Luan, R ^c   Chen, W ^d   Zhan, S ^e   Xu, B ^a  

^a FUDAN UNIVERSITY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c SICHUAN UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY   (China)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cross sectional study; Glycemic control; HbA 1c; Type 2 diabetes mellitus; Urban China

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CHINA; CROSS-SECTIONAL STUDY; FEMALE; GLYCEMIC CONTROL; HUMAN; INTERVIEW; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; SELF MONITORING; STRUCTURED QUESTIONNAIRE; URBAN AREA;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE SELF-MONITORING; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; RISK FACTORS; URBAN POPULATION;

EID: 84862877719     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7743     Document Type: Article

References (22)

1. World Health Organization: Diabetes. www.who.int/mediacentre/factsheets/ fs312/en/index.html. Accessed May 4, 2010.
2. Li LM, Rao KQ, Kong LZ, et al; Technical Working Group of China National Nutrition and Health Survey. A description on the Chinese national nutrition and health survey in 2002. Zhonghua Liu Xing Bing Xue Za Zhi 2005, 26: 478-84.
3. Yang W, Lu J, Weng J, et al; China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362: 1090-101.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352: 837-53.
5. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998, 352: 854-65.
6. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated haemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004, 141: 421-31.
7. LeRoith D, Rayfield EJ. The benefits of tight glycemic control in type 2 diabetes mellitus. Clin Cornerstone 2007, 8 (Suppl 7): S19-29.
8. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358: 2560-72.
9. Tang L, Chen XB, Chen HY, Zhao LY, Hu SL. The health economic study of type 2 diabetes mellitus and its complications in urban China. Zhong Guo Wei Sheng Jing Ji 2003, 22: 21-3.
10. Wang W, Fu C, Pan CY, et al. How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health 2009, 12: 923-9.
11. Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA 2001, 285: 182-9.
12. Williams R, Van Gaal L, Lucioni C; CODE-2 Advisory Board. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 2002, 45: S13-7.
13. Alvarez Guisasola F, Mavros P, Nocea G, Alemao E, Alexander CM, Yin D. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAPDM) study. Diabetes Obes Metab 2008, 10 (Suppl 1): 8-15.
14. Al-Elq AH. Current practice in the management of patients with type 2 diabetes mellitus in Saudi Arabia. Saudi Med J 2009, 30: 1551-6.
15. Chan JC, Gagliardino JJ, Baik SH, et al; IDMPS Investigators. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care 2009, 32: 227-33.
16. Tong PC, Ko GT, So WY, et al. Use of anti-diabetic drugs and glycaemic control in type 2 diabetes-The Hong Kong Diabetes Registry. Diabetes Res Clin Pract 2008, 82: 346-52.
17. Chuang LM, Tsai ST, Huang BY, Tai TY; Diabcare-Asia 1998 Study Group. The status of diabetes control in Asia a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998. Diabet Med 2002, 19: 978-85.
18. Bi Y, Yan JH, Liao ZH, et al. Inadequate glycaemic control and antidiabetic therapy among inpatients with type 2 diabetes in Guangdong Province of China. Chin Med J (Engl) 2008, 121: 677-81.
19. Chinese Diabetes Society. China guideline for type 2 diabetes mellitus (2007). Zhong Hua Nei Fen Mi Dai Xie Za Zhi 2008, 24: 2a-1-2a-27.
20. International Diabetes Federation: Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. http://www.idf.org/webdata/docs/IDF%20GGT2D.pdf. Accessed May 4, 2010.
21. American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care 2006, 29 (Suppl 1): S4-42.
22. World Health Organization and International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia-report of a WHO/IDF consultation. http:// www.who.int/diabetes/ publications/Definition%20and%20diagnosis%20of%20diabetes-new.pdf. Accessed May 4, 2010.